Showing results (561-570 of 4,511) with videos related to

Sort By:
Pageof 452
Future Oncology (London, England)|March 23, 2017
Thoracic radiation therapy could give survival benefit to elderly patients with extensive-stage small-cell lung cancerChangchun An, Wang Jing, Yan Zhang, et al.
Future Oncology (London, England)|March 23, 2017
Polymorphisms of cancer stem cell marker gene CD133 are associated with susceptibility and prognosis of gastric cancerZhi-Fang Jia, Yan-Hua Wu, Dong-Hui Cao, et al.
Future Oncology (London, England)|March 23, 2017
Clinical significance of NDRG3 in patients with breast cancerMehrdad Asghari Estiar, Ali-Akbar Zare, Rezvan Esmaeili, et al.
Future Oncology (London, England)|October 11, 2014
Distinct expression of cytokeratin, N-cadherin and CD133 in circulating tumor cells of metastatic breast cancer patientsCarolin Bock, Brigitte Rack, Jens Huober, et al.
Future Oncology (London, England)|September 19, 2014
Treatment options in HR⁺/HER2⁻ advanced breast cancer patients pretreated with nonsteroidal aromatase inhibitors: what does current evidence tell us?Sabino De Placido, Paolo Pronzato
Future Oncology (London, England)|September 20, 2014
HDGF: a novel jack-of-all-trades in cancerCihang Bao, Jianbo Wang, Wei Ma, et al.
Future Oncology (London, England)|July 31, 2014
Radium 223 dichloride: a multidisciplinary approach to metastatic castration-resistant prostate cancerElisa Borsò, Giuseppe Boni, Luca Galli, et al.
Future Oncology (London, England)|July 23, 2014
Soft tissue sarcomas, a look into the future: different treatments for different subtypesPeter Reichardt
Future Oncology (London, England)|July 24, 2014
Carboplatin plus etoposide in heavily pretreated castration-resistant prostate cancer patientsCarlo Buonerba, Piera Federico, Davide Bosso, et al.
Future Oncology (London, England)|July 24, 2014
Targeted therapies in advanced renal cell carcinoma: the role of metastatic sites as a prognostic factorPaolo Grassi, Elena Verzoni, Luca Porcu, et al.
Pageof 452